Results 111 to 120 of about 10,659 (202)

Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study. [PDF]

Yonsei Med J
Nguyen MH, Ko J, Cho J.
europepmc   +1 more source

The effects of dutasteride and tamsulosin, alone or in association, in the kidney morphology: experimental study in rats. [PDF]

Acta Cir Bras
Silva MHAD, Ferreira SG, Gregório BM, Sampaio FJ, Souza DB.   +4 more
europepmc   +1 more source

The efficacy of tamsulosin 0.4 mg when tamsulosin 0.2 mg is insufficient for benign prostatic hyperplasia in Korean patients. [PDF]

Investig Clin Urol
Chung Y, Jeong SJ, Song SH, Hong SK.
europepmc   +1 more source

A fixed dose combination of tamsulosin and tadalafil in men with benign prostatic hyperplasia and erectile dysfunction: a prospective, multicenter, phase IV study. [PDF]

World J Urol
Gupta C, S AT, Pawar DS, Khandekar A, Deshmukh GR, Kumar V, Ramesh AV, Hemantkumar SI, Balkrishna PS, Rajurkar M, Sonawane D, Patil D, Ghadge P, Mehta S.   +13 more
europepmc   +1 more source

Quantum Biochemistry Insights into Ligand Recognition at the a_1A-Adrenoceptor. [PDF]

ACS Omega
Talinne da Costa Gomes L, Bezerra KS, Gavioli EC, Nobre Oliveira JI, Galvão DS, Fulco UL, Dantas da Silva Junior E.   +6 more
europepmc   +1 more source

Tamsulosin And Corticosteroid In The Medical Expulsive Therapy For Distal Ureteral Stones: A Prospective Comparative Study

Journal of Society of Surgeons of Nepal
Introduction: Medical Expulsive Therapy (MET) has become an established treatment option for small ureteral stones. While alpha blockers are commonly used agents, the addition of anti-inflammatory medications such as corticosteroids seems to increase ...
Hari Bahadur KC, Suman Sharma
doaj  

Correlation between intravesical prostatic protrusion and ejaculatory dysfunction after tamsulosin treatment in men with BPH. [PDF]

World J Urol
Gezmiş CT, Çilesiz NC, Kartal VH, Altan MK, Çakıroğlu B, Balcı MBC.   +5 more
europepmc   +1 more source

Understanding the ureter: challenges and opportunities [PDF]

, 2016
Park, Alyssa, Venkatesh, Ramakrishna
core   +2 more sources

Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review. [PDF]

Transl Androl Urol
Bakhsh A, Rajih E, Barayan GA, Garah E, Khan I, Alrehaili Z, Alhejaili S, Almuways M, Aloufi T, Alnazawi H, Alharbi A, Farghal D, Badawi A.   +12 more
europepmc   +1 more source

Doxazosin versus tamsulosin for the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic literature review and network meta-analysis. [PDF]

World J Urol
Oelke M, Cornu JN, Chopra I, Herrmann TRW, Hassan T.   +4 more
europepmc   +1 more source